Town & Country Bank Investor Activity Analysis: Q2 2026 Portfolio Changes

As part of its ongoing investment strategy, Town & Country Bank & Trust Co Dba First Bankers Trust Co made several notable adjustments to its portfolio during the second quarter of 2026. The bank's holdings saw changes across various sectors, reflecting a dynamic approach to asset management.

Significant Sales Observed in Q2 2026

The investor recorded substantial reductions in certain positions this quarter:

• ABT, representing ABBOTT LABORATORIES, experienced a significant sell-off with shares decreasing by 62.35%. This substantial reduction in holdings reflects a major shift away from this healthcare stock.
• DKS, symbol for DICKS SPORTING GOODS INC, saw an 85.72% decrease in shares held by the investor during Q2.
• ROP, CADER ROPPER TECHNOLOGIES INC, was sold completely as its position decreased by 100%, meaning all previously held shares were disposed of.

Major Purchases and Increased Holdings in Q2 2026

In contrast to the exits, Town & Country Bank significantly increased its exposure to several companies:

• The investor dramatically boosted its position in NTR, NUTRIEN LTD. This purchase represented an increase of 100% in shares, indicating a strong confidence in this basic materials company.
• Similarly, the position in PLD, PROLOGIS INC., increased by 100%, suggesting renewed interest in real estate investment trusts during this period.

New Positions Added This Quarter

Expanding its portfolio, Town & Country Bank acquired stakes in several new companies:

• BF-A, BROWN FORMAN CORP (preferred), was added to the investor's holdings.
• BF-B, BROWN FORMAN CORP (common), also represents a new position initiated this quarter.
• The investor established a position in GLW, symbol for CORNING INC, acquiring shares during Q2 2026.
• Additionally, the bank invested in PEP, PEPSICO INC, creating a new holding.
• The investor also added shares of KNG, FIRST TR EXCHANGE-TRADED FD (likely First Trust Exchange-Traded Fund).
• Furthermore, the bank invested in BTAL, AGF INVTS TR (AGF Investments Trust), marking another new position.

Purchase Details: ABBV and SYK

While focusing on changes, it's also important to note purchases that didn't necessarily double the stake but still represent significant additions:

• ABBV, ABBVIE INC (which owns the rights to AbbVie's portfolio), saw its position increase by 18.07% during Q2.
• The investor significantly increased its stake in SYK, STRYKER CORPORATION, with a share increase of approximately 45.9%, representing substantial buying activity focused on this healthcare equipment maker.

The overall portfolio value stood at $316,211,598 as of June 30th, 2026, reflecting the net effect of these changes and other minor adjustments throughout the quarter. The investor continues to diversify across sectors while making targeted decisions on specific holdings.